Objectives: To determine haematological parameters in fetuses affected by homozygous α 0-thalassemia. Methods: This was a cross-sectional retrospective study reviewing 546 blood samples (268 fetal and 278 neonatal cord) being collected between 1993 and 2006, from 12 weeks' gestation onwards for any indication, including the prenatal diagnosis of homozygous α 0-thalassemia, other haematological disorders, hydrops or aneuploidy. The proportion of haemoglobin (Hb) fractions was determined by electrophoresis of haemolysate on cellulose acetate in all samples. Results: There were significant differences in the haematological parameters between homozygous α 0-thalassemia (n = 183) and control (n = 363) which were either heterozygous α 0-thalassem...
BACKGROUND: The physiological fall in haemoglobin concentration from the 1st to the 3rd trimester of...
Objective: To determine the utility of the mean corpuscular hemoglobin (MCH) as a screening modality...
Objective: To evaluate the use of placental volume measured by three-dimensional (3D) ultrasound in ...
Objectives: To determine hematological parameters in fetusesaffected by α0-thalassemiaMethods: This ...
Objective. Fetuses affected by homozygous α-thalassemia-1 develop anemia as early as the first trime...
OBJECTIVE: Maternal serum free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasm...
Objective: To show the experience of prenatal diagnosis of Thalassemia and hemoglobinopathies in Sir...
Objective. Fetuses affected by homozygous α-thalassemia-1 are anemic in the first trimester. We stud...
Texto completo: acesso restrito. p. 29–34α-Thalassemia is a synthesis hemoglobinopathy with a worldw...
a-Thalassemia is a synthesis hemoglobinopathy with a worldwide distribution. a-thalassemia- 23.7kb (...
Aim: To investigate whether in Malaysia, a mean corpuscular volume (MCV) less than 80 f1 and mean co...
Texto Completo: acesso restrito. p. 29–34a-Thalassemia is a synthesis hemoglobinopathy with a worldw...
Objective: To determine the prevalence of thalassemia including α-thalassemia-1 trait (SEA type), β-...
aims: This study was done to determine the relationship between maternal haemoglobin and fetal weigh...
Introduction: Hemoglobinopathies are diverse group of inherited disorders of hemoglobin production a...
BACKGROUND: The physiological fall in haemoglobin concentration from the 1st to the 3rd trimester of...
Objective: To determine the utility of the mean corpuscular hemoglobin (MCH) as a screening modality...
Objective: To evaluate the use of placental volume measured by three-dimensional (3D) ultrasound in ...
Objectives: To determine hematological parameters in fetusesaffected by α0-thalassemiaMethods: This ...
Objective. Fetuses affected by homozygous α-thalassemia-1 develop anemia as early as the first trime...
OBJECTIVE: Maternal serum free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasm...
Objective: To show the experience of prenatal diagnosis of Thalassemia and hemoglobinopathies in Sir...
Objective. Fetuses affected by homozygous α-thalassemia-1 are anemic in the first trimester. We stud...
Texto completo: acesso restrito. p. 29–34α-Thalassemia is a synthesis hemoglobinopathy with a worldw...
a-Thalassemia is a synthesis hemoglobinopathy with a worldwide distribution. a-thalassemia- 23.7kb (...
Aim: To investigate whether in Malaysia, a mean corpuscular volume (MCV) less than 80 f1 and mean co...
Texto Completo: acesso restrito. p. 29–34a-Thalassemia is a synthesis hemoglobinopathy with a worldw...
Objective: To determine the prevalence of thalassemia including α-thalassemia-1 trait (SEA type), β-...
aims: This study was done to determine the relationship between maternal haemoglobin and fetal weigh...
Introduction: Hemoglobinopathies are diverse group of inherited disorders of hemoglobin production a...
BACKGROUND: The physiological fall in haemoglobin concentration from the 1st to the 3rd trimester of...
Objective: To determine the utility of the mean corpuscular hemoglobin (MCH) as a screening modality...
Objective: To evaluate the use of placental volume measured by three-dimensional (3D) ultrasound in ...